Thursday, August 11, 2022

Moderna

Moderna Announces Strategy to Address Omicron (B.1.1.529) SARS-CoV-2 Variant

Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced updates to its strategy to address SARS-CoV-2 variants of concern, given the emergence of the B.1.1.529 (Omicron) variant. The recently described Omicron variant includes mutations...
- Advertisement -spot_img

Latest News

World must notice Indian repressions in IIOJ&K, says Qamar Zaman Kaira to a webinar in Canada

Like Pakistan and elsewhere in the world, Youm e Istehsal Kashmir was observed in Canada by the Pakistan High...
- Advertisement -spot_img